Related references
Note: Only part of the references are listed.Tetrac downregulates beta-catenin and HMGA2 to promote the effect of resveratrol in colon cancer
Andre Wendindonde Nana et al.
ENDOCRINE-RELATED CANCER (2018)
Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells
Meng-Ti Hsieh et al.
ONCOTARGET (2017)
Resveratrol inhibits ovarian tumor growth in an in vivo mouse model
Lijun Tan et al.
CANCER (2016)
Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway
Senthil Selvaraj et al.
MOLECULAR CARCINOGENESIS (2016)
Predictive biomarkers of response to PD-1/PD-L1 immune checkpoint inhibitors in non-small cell lung cancer
Kazuhiko Shien et al.
LUNG CANCER (2016)
Actions of L-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells
Hung-Yun Lin et al.
STEROIDS (2016)
PD-L1 expression in human cancers and its association with clinical outcomes
Xin Wang et al.
ONCOTARGETS AND THERAPY (2016)
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia-Wei Li et al.
NATURE COMMUNICATIONS (2016)
Actions of Thyroid Hormone Analogues on Chemokines
Paul J. Davis et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Thyroid Hormone, Cancer, and Apoptosis
Hung-Yun Lin et al.
COMPREHENSIVE PHYSIOLOGY (2016)
Resveratrol and cancer: Challenges for clinical translation
Chandra K. Singh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Frequent PD-L1 expression in testicular germ cell tumors
C. D. Fankhauser et al.
BRITISH JOURNAL OF CANCER (2015)
Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways
Guangxiu Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
Sandip Pravin Patel et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Frequent expression of PD-L1 on circulating breast cancer cells
Martine Mazel et al.
MOLECULAR ONCOLOGY (2015)
Resveratrol Induces Glioma Cell Apoptosis through Activation of Tristetraprolin
Jinhyun Ryu et al.
MOLECULES AND CELLS (2015)
Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma
Patcharee Ritprajak et al.
ORAL ONCOLOGY (2015)
Mechanisms of dihydrotestosterone action on resveratrol-induced anti-proliferation in breast cancer cells with different ER status
Yu-Tang Chin et al.
ONCOTARGET (2015)
PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells
Kathleen M. Mahoney et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial
Caroline Robert et al.
LANCET (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
PD-L1 and MHC-I expression in 19 human tumor cell lines and modulation by interferon-gamma treatment
Italia Grenga et al.
Journal for ImmunoTherapy of Cancer (2014)
PD-L1 on Tumor Cells Is Induced in Ascites and Promotes Peritoneal Dissemination of Ovarian Cancer through CTL Dysfunction
Kaoru Abiko et al.
CLINICAL CANCER RESEARCH (2013)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol
Hung-Yun Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Small Molecule Hormone or Hormone-Like Ligands of Integrin αVβ3: Implications for Cancer Cell Behavior
Paul J. Davis et al.
HORMONES & CANCER (2013)
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
Laurence Zitvogel et al.
ONCOIMMUNOLOGY (2012)
Resveratrol and apoptosis
Hung-Yun Lin et al.
RESVERATROL AND HEALTH (2011)
Bioavailability of resveratrol
Thomas Walle
RESVERATROL AND HEALTH (2011)
Inducible COX-2-dependent apoptosis in human ovarian cancer cells
Cassie Lin et al.
CARCINOGENESIS (2011)
Resveratrol bioavailability and toxicity in humans
Charles-Henry Cottart et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2010)
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
Luis Almeida et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated
Hung-Yun Lin et al.
CARCINOGENESIS (2008)
被撤回的出版物: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic (Retracted article. See vol. 195, 2023)
Hung-Yun Lin et al.
STEROIDS (2007)
Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats
SH Tseng et al.
CLINICAL CANCER RESEARCH (2004)
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Y Iwai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Share Paper
